Clinical Trial Update: Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of brexucabtagene autoleucel (Tecartus) with dasatinib in adults with acute lymphoblastic leukemia; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Sprycel (dasatinib)
• Tecartus (brexucabtagene autoleucel)

Snippet

Sponsor: Stanford University | Conditions: Lymphoblastic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING